A two-day online menopause summit, the product that monetises it, and what the model returns at scale.
Three quarters of women in menopause are not treated.
Not undiagnosed. Symptomatic, aware, and not receiving care. Most primary care physicians receive very little menopause training, which is a curriculum problem rather than a scandal, and it means the burden of the conversation lands on the patient.
The gap is not information. Free information is abundant and the category is saturated with it. The gap is access and advocacy: finding a clinician who has actually trained in this, and knowing what to ask inside a twelve-minute appointment.
The gap is non-clinical, which means it can be served by a publisher rather than a provider. That is the whole business, and it is the reason a host without a medical credential is the right person to build it.
Two days, online, 24 sessions across 12 clinicians. Free to register, free to watch live in a 48-hour window, then the replays close. Live three or four times a year with an evergreen replay funnel in between.
Amy Simon hosts. Twenty years as a television host and spokesperson. She convenes, frames and asks the question the audience is thinking. She is not a clinician, does not present as one, and gives no medical guidance at any point. The speakers carry the medicine; she carries the room.
No outcome claims anywhere. No diagnosis, no hormone or dosage recommendations, no supplement claims. Every speaker is introduced with credentials and affiliation, and commercial interests are disclosed on screen. Advertising is framed at the category, never at the reader, because health status is a protected attribute under Meta's 2026 rules.
The All-Access Pass is the business. It produces roughly seven times what the high-ticket programme does. Every instinct carried over from a coaching funnel is wrong here, and that inversion is precisely why a host without a medical credential can build it: the item that makes the money requires none.
The pass exists because the summit creates a specific problem. She has just heard twelve clinicians say forty things and has no idea what to do on Monday. Twenty hours of excellent content is not a plan. The pass is the layer between information and treatment: every session permanently, a symptom-to-session index, an appointment kit, twelve speaker bonuses and a ninety-day tracker.
| Conservative | Base (live) | Optimistic | |
|---|---|---|---|
| CPL / pass conversion | $7 / 3% | $5 / 5% | $5 / 7% |
| All-access pass | $381,000 | $735,000 | $1,379,000 |
| Bump and course upsell | $99,030 | $165,050 | $231,070 |
| Group programme | $103,125 | $103,125 | $103,125 |
| Membership | $50,000 | $50,000 | $50,000 |
| Partner and affiliate | $40,000 | $100,000 | $180,000 |
| Sponsorship | $20,000 | $60,000 | $60,000 |
| Revenue | $693,155 | $1,213,175 | $2,003,195 |
| Ad spend | ($700,000) | ($500,000) | ($500,000) |
| All other cost | ($260,532) | ($311,814) | ($395,477) |
| Net | ($267,377) | ||
| Net | $401,361 | $1,107,718 |
A live summit cannot run monthly. Speakers will not re-record and the audience depletes. Three or four live events a year with evergreen replays between, and evergreen converts at roughly 60 to 70% of live.
| Months | Net each | Total | |
|---|---|---|---|
| Live summit months | 3 | $401,361 | $1,204,083 |
| Evergreen months | 9 | $103,232 | $929,088 |
| Year one at full volume | 12 | $2,133,171 |
Roughly $12.6M revenue and $2.1M net, about $178,000 a month blended. Not $400,000. Anyone quoting the live-month figure as a run rate is quoting a peak.
| CPL | Pass 3% | Pass 5% | Pass 7% |
|---|---|---|---|
| $5 | +$85K | +$401K | +$1,108K |
| $6 | ($15K) | +$301K | +$1,008K |
| $7 | ($267K) | +$201K | +$908K |
Registrant CPL and pass conversion. At $7 and 3% the model loses a quarter of a million dollars a month. At $5 and 5% it makes four hundred thousand. Same traffic, same product, same team.
100,000 a month is probably above the efficient frontier. Half a million dollars a month against women 45 to 60 on Meta is a large share of that inventory and CPL climbs as you take more of it. Ramp 30K, then 60K, then toward 100K, watching CPL at each step.
The category is consolidating rather than emerging. Midi Health has raised $250M, The 'Pause Life reached $43M in revenue, and its founder is now Chief AgeWell Officer at Midi. The summit format sidesteps the authority contest, because a convener is not competing with a clinician. It does not sidestep the traffic auction.
Those same funded companies are in a customer land grab. A warm audience of 100,000 women aged 45 to 60 a month is exactly what they pay to acquire. Partner revenue is modelled at $100K a month and could plausibly be the largest line on the sheet, at close to pure margin. It should be negotiated before spend scales, not after, because partner economics determine what CPL the model can afford.
The registration page and the pass sales page exist and are live for review. The market research, the product definition and the full model are documented. What does not exist is the traffic data, and that is the only thing standing between this brief and a decision.